Skip to content
★ Sign in to follow
TI

Thomas I. H. Dubin

Executive
Notable Labs, Ltd.Alexion Pharmaceuticals Inc
Total declarations
145
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (54 ops.)
€50.4M

Latest filing published 10 May 2024 for Notable Labs, Ltd..

Insider track record

Disclosed buys
0
Disclosed sells
54
Signal history

No signal scores available.

Thomas I. H. Dubin: trading record in brief

Thomas I. H. Dubin discloses dealings in 2 companies, chiefly Alexion Pharmaceuticals Inc and Notable Labs, Ltd. In total, 145 filings cover trades dated from 9 January 2006 to 8 May 2024.

No open-market purchase appears, only 54 sales worth €50.4M. Besides market trades, the filings include 8 share grants and 80 option exercises.

The latest filing, published on 10 May 2024, reports a share grant in Notable Labs, Ltd. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas I. H. Dubin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations137 total

25 of 137 declarations